Email Alerts
Careers
Contact Us
Home
About Us
Overview
Leadership
Board of Directors
Scientific Advisory Board
Partnerships
Careers
Contact
Product
ibrexafungerp
Patent
Pipeline
Ibrexafungerp Development Pipeline
Clinical Trials
Vulvovaginal Candidiasis
Refractory Invasive Fungal Infections
Invasive Candidiasis
Invasive Aspergillosis
Science
SCYNEXIS Research Platform
Publications and Presentations
Expanded Access
News
Press Releases
Events
Investors
Overview
News Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Data
You are now leaving the SCYNEXIS Corporate Website.
I understand
Cancel
SEC Filings
Investors
Investors
Overview
News Releases
Press Releases
Email Alerts
Events & Presentations
IR Calendar
Presentations
Governance
Leadership
Board of Directors
Board Committees
Governance Documents
Financials & Filings
SEC Filings
Annual Reports
Proxy Statements
Quarterly Results
Key Ratios
Stock Data
Quote
Historical Data
Investor Calculator
Analyst Coverage
Ownership Profile
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Financials & Filings
SEC Filings
Annual Reports
Proxy Statements
Quarterly Results
Key Ratios
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
FWP
NT 10-Q
PRE 14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2008
2006
2002
Date
Form
Description
PDF
XBRL
Pages
01/26/21
3
Initial statement of beneficial ownership of securities
2
01/08/21
EFFECT
Notice of Effectiveness
1
01/06/21
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
1
01/06/21
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
12/31/20
S-3
Registration statement for specified transactions by certain issuers
Documents
EX-5.1
EX-23.1
40
12/23/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
6
12/23/20
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
12/23/20
4
Statement of changes in beneficial ownership of securities
2
12/23/20
4
Statement of changes in beneficial ownership of securities
2
12/23/20
4
Statement of changes in beneficial ownership of securities
2
4
5
6
7
8
9
10
11
12
13